Cronos Group Inc. (CRON)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.81
-0.88%
Mkt Cap $1.08B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$3.15
Range $2.30 – $4.50
Implied Upside
+12.1%
Consensus $3.15 vs current $2.81